MIM
THRN

Monashee Investment Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Monashee Investment Management’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-111,250
Closed -$708K – 50
2022
Q1 		$708K Sell
111,250
-100,000
-47% -$538K 0.21% 31
2021
Q4 		$1.31M Sell
211,250
-145,000
-41% -$1.13M 0.32% 36
2021
Q3 		$3.08M Buy
+356,250
New +$2.91M 0.57% 38

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Monashee Investment Management's THRN Position: Q2 2022 in Review

Monashee Investment Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q2 2022, closing a stake of 111,250 shares — an estimated $708K sold.

Monashee Investment Management first reported a position in THRN in Q3 2021 and held it in 3 quarters. The position peaked at $3.08M in Q3 2021. 49 funds tracked by Wall St. Rank hold THRN as of Q2 2022.

  • Monashee Investment Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Monashee Investment Management sold 111,250 Thorne Healthtech, Inc. Common Stock shares in Q2 2022, an estimated $708K.
  • Monashee Investment Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Monashee Investment Management's Thorne Healthtech, Inc. Common Stock position peaked at $3.08M in Q3 2021.
  • 49 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q2 2022.

Based on Monashee Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.